Background and Aims: Odontogenic keratocyst (OKC) is a radiolucent jaw lesion often mistaken for similar conditions like ameloblastomas on panoramic radiographs. Accurate diagnosis is vital for effective management, but manual image interpretation can be inconsistent. While deep learning algorithms in AI have shown promise in improving diagnostic accuracy for OKCs, their performance across studies is still unclear. This systematic review and meta‐analysis aimed to evaluate the diagnostic accuracy of AI models in detecting OKC from panoramic radiographs.Methods: A systematic search was performed across 5 databases. Studies were included if they examined the PICO question of whether AI models (I) could improve the diagnostic accuracy (O) of OKC in panoramic radiographs (P) compared to reference standards (C). Key performance metrics including sensitivity, specificity, accuracy, and area under the curve (AUC) were extracted and pooled using random‐effects models. Meta‐regression and subgroup analyses were conducted to identify sources of heterogeneity. Publication bias was evaluated through funnel plots and Egger's test.Results: Eight studies were included in the meta‐analysis. The pooled sensitivity across all studies was 83.66% (95% CI:73.75%–93.57%) and specificity was 82.89% (95% CI:70.31%–95.47%). YOLO‐based models demonstrated superior diagnostic performance with a sensitivity of 96.4% and specificity of 96.0%, compared to other architectures. Meta‐regression analysis indicated that model architecture was a significant predictor of diagnostic performance, accounting for a significant portion of the observed heterogeneity. However, the analysis also revealed publication bias and high variability across studies (Egger's test, p = 0.042).Conclusion: AI models, particularly YOLO‐based architectures, can improve the diagnostic accuracy of OKCs in panoramic radiographs. While AI shows strong capabilities in simple cases, it should complement, not replace, human expertise, especially in complex situations.
Background: Methicillin‐resistant Staphylococcus aureus poses a serious threat to global health due to its resistance to conventional antibiotics and its ability to form resilient biofilms. Cold atmospheric plasma has emerged as a promising alternative for microbial biofilm inactivation. Objective: To systematically evaluate the in vitro efficacy of cold atmospheric plasma in disrupting or eradicating methicillin‐resistant Staphylococcus aureus biofilms and to identify factors influencing treatment outcomes Methods: A comprehensive search was conducted in five databases (PubMed/MEDLINE, Embase, Scopus, Web of Science, and Google Scholar) for in vitro studies published up to July 2025. Eligible studies assessed cold atmospheric plasma effects on methicillin‐resistant Staphylococcus aureus biofilms. Data were extracted on study characteristics, cold atmospheric plasma device parameters, exposure conditions, and microbial outcomes. Risk of bias was assessed using a modified version of the ToxRTool. Results: Seventeen in vitro studies were included. Most studies originated from European countries ( n = 10), with a peak in publications observed in 2021. Dielectric barrier discharge and plasma jets were the most common devices. Air‐based plasmas were the most commonly used in 12 studies, followed by helium. All studies reported cold atmospheric plasma‐mediated reductions in methicillin‐resistant Staphylococcus aureus biofilm load, with log 10 colony‐forming unit reductions ranging from 1 to > 6, depending on exposure time, surface material, and device configuration. Several studies demonstrated near‐complete biofilm eradication within minutes. Synergistic effects were observed when cold atmospheric plasma was combined with antibiotics. Conclusions: These findings suggest that cold atmospheric plasma may have potential as an adjunctive strategy for biofilm‐related infection control, although further standardized and clinically relevant studies are needed.